ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0969

Loss of Balance Between Protective and Pro-inflammatory Synovial Tissue T Cell Polyfunctionality Predates Clinical Onset of Rheumatoid Arthritis

Achilleas Floudas1, Nuno Neto2, Carl Orr3, Mary Canavan4, Phil Gallagher3, Conor Hurson5, Michael Monaghan2, Nagpar Sunil6, Ronan Mullan7, Douglas Veale8 and Ursula Fearon2, 1Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Ireland, 2Trinity College Dublin, Dublin, Ireland, 3St Vincent's Hospital, Dublin, Ireland, 4Trinity College, Santry, Ireland, 5St Vincents University Hospital, Dublin, Ireland, 6Janssen R&D, Spring House, PA, 7Tallaght University Hospital, Dublin, Ireland, 8University College Dublin, Dublin, Ireland

Meeting: ACR Convergence 2021

Keywords: Individuals at risk, Metabolism, rheumatoid arthritis, synovial tissue, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (0966–0969)

Session Type: Abstract Session

Session Time: 11:15AM-11:30AM

Background/Purpose: Effective treatment of Rheumatoid arthritis (RA) patients is achievable within a short window of opportunity. T-cells are early drivers of synovial inflammation of RA, therefore, identification of pathogenic T-cell subsets at the synovial tissue of pre-RA, individuals at risk (IAR), would greatly improve our understanding of disease pathogenesis. Comparative analysis of healthy control, IAR subject and RA-patient derived synovial tissue T-cell responses will lead to the identification of pathogenic as well as protective cytokine milieu, thus enabling the identification of early therapeutic targets to help steer the immune response towards resolution.

Methods: Synovial biopsies from RA, IAR and HC by arthroscopic surgery followed by RNAseq analysis (Guo et al., PLoS One, 2018). Single cell synovial tissue cell suspensions from RA, IAR and HC and paired PBMC were stimulated in vitro and polyfunctional synovial T-cell subsets examined by flow cytometric analysis, SPICE visualization and FlowSom clustering. Flow-Imaging, was utilised to confirm T-cell cluster identification. Fluorescent Lifetime Imaging Microscopy (FLIM) was used to visualise metabolic status of specific T-cell populations.

Results: T-cell associated pro-inflammatory gene pathways were increased in RNAseq analysis of RA-patient and IAR compared to HC synovial tissue biopsies. Flow cytometric analysis of pro-inflammatory cytokine (TNF-a, IFN-γ, IL-2, GM-CSF, IL-17A, IL-22) production and SPICE analysis of ex vivo stimulated T-cells revealed marked polyfunctionality of IAR synovial T-cells, thus providing evidence for a dysregulated synovial T-cell response that pre-dates clinical onset of disease. Importantly, HC synovial tissue harbours a small, albeit surprisingly polyfunctional, CD4 T-cell population characterised by significantly increased IL-4 and GM-CSF cytokine production compared to arthralgia subject (P< 0.001 and P=0.01) and RA-patient (P< 0.001 and P=0.004) synovial tissue. However, not all polyfunctional T-cells are equal in their pathogenic potential. Therefore, in order to identify highly pathogenic synovial T-cells, cluster analysis of flow cytometric data using the unsupervised algorithm FlowSom was performed and led to the identification of specific T-cell clusters with unique polyfunctionality characteristics. Specifically a cluster of CD4+CD8+ double positive (DP) T-cells with high polyfunctionality scores was identified. Hybrid flow cytometry and imaging technique confirmed the co-expression of CD4 and CD8 by a synovial T-cell population. DP T-cells are enriched in RA-patient synovial fluid and synovial tissue and IAR synovial tissue, but are absent from HC synovial tissue. Importantly, DP T-cell synovial accumulation strongly (P=0.002) correlates with DAS28(CRP) of RA-patients. Utilisation of the novel, non-invasive FLIM technique for visualisation of cellular NAD, revealed that DP T-cells have a metabolic profile indicative of activated memory T-cells.

Conclusion: These data highlight a key early loss of balance between protective and pathogenic synovial T-cell polyfunctionality and the emergence of specific, highly polyfunctional and pathogenic T-cell clusters in RA.

A. FlowSom unsupervised clustering algorithm analysis of RA patient synovial CD3+ T cells for the identification of phenotypically distinct highly polyfunctional T cell clusters. Symbols indicate polyfunctional CD4+CD8+ DP T cells. B. Representative flow cytometric analysis of paired RA patient peripheral blood, synovial fluid and synovial tissue CD3+ T cells. C. Frequency of CD4+CD8+ DP T cells in the periphery (n=34), synovial fluid (n=13), and synovial tissue (n=7), of RA patients. D. Frequency of CD4+CD8+ DP T cells in the periphery and synovial tissue of HC (n=11 and n=5 respectively), IAR (n=13 and n=6 respectively), subjects and RA (n=34 and n=7 respectively) patients. E. Representative imaging flow cytometry of RA patient synovial fluid CD4+, CD8+ and CD4+CD8+ DP T cells. F. FLIM images and cumulative data of RA patient flow sorted peripheral blood CD4+ and CD4+CD8+ DP T cells, (n=5). H. Linear regression graph for the synovial tissue frequency of RA (n=8) patient CD4+CD8+ DP T cells and disease severity score (DAS28-CRP).


Disclosures: A. Floudas, None; N. Neto, None; C. Orr, None; M. Canavan, None; P. Gallagher, None; C. Hurson, None; M. Monaghan, None; N. Sunil, None; R. Mullan, None; D. Veale, Abbvie, 1, 5, 6, BMS, 1, 5, Pfizer, 1, 5, 6, Janssen, 1, 5, 6, Eli Lilly, 1, 5, 6, UCB, 1, 5, 6, Novartis, 1, 5, 6, Galapagos/Gilead, 1, 6; U. Fearon, Abbvie, 1, 5, 6, BMS, 1, Pfizer, 1, 5, Janssen, 5, Eli Lilly, 5, UCB, 5, GSK, 6.

To cite this abstract in AMA style:

Floudas A, Neto N, Orr C, Canavan M, Gallagher P, Hurson C, Monaghan M, Sunil N, Mullan R, Veale D, Fearon U. Loss of Balance Between Protective and Pro-inflammatory Synovial Tissue T Cell Polyfunctionality Predates Clinical Onset of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/loss-of-balance-between-protective-and-pro-inflammatory-synovial-tissue-t-cell-polyfunctionality-predates-clinical-onset-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/loss-of-balance-between-protective-and-pro-inflammatory-synovial-tissue-t-cell-polyfunctionality-predates-clinical-onset-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology